11-6392020-G-C
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The NM_000543.5(SMPD1):c.955G>C(p.Gly319Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000205 in 1,461,894 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 12/20 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000543.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251460Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135900
GnomAD4 exome AF: 0.00000205 AC: 3AN: 1461894Hom.: 0 Cov.: 36 AF XY: 0.00000413 AC XY: 3AN XY: 727248
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Niemann-Pick disease, type A Pathogenic:2Uncertain:1
- -
The missense variant p.G319R in SMPD1 (NM_000543.5) has been previously reported in homozygous state in an affected patient of Indian origin (Ranganath P et al, 2016). The variant has been submitted to ClinVar as Uncertain significance. The p.G319R variant is observed in 1/1,13,740 (0.0009%) alleles from individuals of European (Non-Finnish) background in gnomAD Exomes and is novel (not in any individuals) in 1000 Genomes. The p.G319R missense variant is predicted to be damaging by both SIFT and PolyPhen2. The glycine residue at codon 319 of SMPD1 is conserved in all mammalian species. The nucleotide c.955 in SMPD1 is predicted conserved by GERP++ and PhyloP across 100 vertebrates. For these reasons, this variant has been classified as Likely Pathogenic. -
- -
Niemann-Pick disease, type B Pathogenic:2
The variant is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: <0.001%). In silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: 0.98; 3Cnet: 1.00). Same nucleotide change resulting in same amino acid change has been previously reported to be associated with SMPD1-related disorder (ClinVar ID: VCV000555444 / PMID: 27338287). The variant has been reported to be in trans with a pathogenic variant as either compound heterozygous or homozygous in at least one similarly affected unrelated individual (PMID: 27338287). A different missense change at the same codon (p.Gly319Ser) has been reported to be associated with SMPD1-related disorder (ClinVar ID: VCV000992693). Therefore, this variant is classified as Likely pathogenic according to the recommendation of ACMG/AMP guideline. -
- -
Niemann-Pick disease, type A;C0268243:Niemann-Pick disease, type B Pathogenic:1
This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 319 of the SMPD1 protein (p.Gly319Arg). This variant is present in population databases (rs757934797, gnomAD 0.0009%). This missense change has been observed in individual(s) with Niemann-Pick disease type A (PMID: 27338287). ClinVar contains an entry for this variant (Variation ID: 555444). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SMPD1 protein function. Experimental studies have shown that this missense change affects SMPD1 function (PMID: 34273913). For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at